Unknown

Dataset Information

In silico analysis of noscapine compounds as anti-tumor agents targeting the tubulin receptor.


ABSTRACT:

Objective

This research aims to develop a mathematical model that relates the structural features of noscapine with anti-tumor activity, to explains the mode of binding between noscapine compounds and the target receptor tubulin by docking analysis. By considering the results of docking analysis and predictions of pharmacokinetic properties/drug likeness, we designed novel noscapine compounds as anti-tumor agents against pancreatic cancer.

Methods

We used an in silico quantitative structure-activity relationship (QSAR) approach, molecular docking analysis and online tools for pharmacokinetics and drug likeness prediction to develop novel compounds.

Results

A QSAR model with good validations parameters and quality of fit (R2 = 0.9731, Q2

SUBMITTER: Nulamuga B 

PROVIDER: S-EPMC9643549 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature